hypercholesterolemia Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

cholesterol

A

steroid released by the liver and intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cholesterol function

A

regulates cell membrane fluidity and helps produce vitamin D, steroids and bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

triglyceride pathway

A

triglycerides get transported by VLDL from the liver or chylomicrons from the intestines to adipose tissue for energy and storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cholesterol pathway

A

cholesterol gets transported by LDL for plasma membranes and steroid synthesis or HDL for excess to be converted into bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

atherosclerosis

A

lipid deposition and plaque reaches critical point where disruption occurs and overlying thrombus forms which obstructs blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hypercholesterolemia causes (8)

A

diabetes, hyperthyroidism, pregnancy, menopause, CKD, liver disease, gout, FH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

normal total cholesterol

A

<5 mmol/L or <200 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

normal HDL

A

> 1 mmol/l or 40-60 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

normal LDL

A

<3 mmol/l or <100 mg/dl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

normal non-HDL

A

<4 mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

normal triglycerides

A

<2.3 mmol/l

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

familial hypercholesterolemia

A

autosomal dominant disorder involving high LDL-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

heterozygous familial hypercholesterolemia

A

inherited mutation from one parent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

homozygous familial hypercholestrolemia

A

inherited mutation from both parents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hypercholesterolemia diagnosis

A

total cholesterol >7.5 mmol, check personal or family history of premature CHD, check SBC or DLCN criteria and refer to DNA testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hypercholesterolemia monitoring

A

full lipid profile, liver function tests, renal function, HbA1C, TFTs, creatine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

full lipid profile

A

aim for >40% reduction in non-HDL-C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

liver function test

A

do not start statins if transaminases >3x upper limit, repeat at 3 months and 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

renal function test

A

low statin dose if severe impairment

20
Q

haemoglobin A1C test

A

can diagnose diabetes

21
Q

thyroid function test

A

can diagnose hypothyroidism

22
Q

creatine kinase

A

low statin dose if raised <5x upper limit and persistent muscle pain prior to starting; stop statin if >5x upper limit or experiencing pain

23
Q

statins function

A

reduce cholesterol synthesis in the liver by inhibiting HMG-CoA reductase

24
Q

high-intensity regimen

A

statin dose that reduces LDL-C by >50%

25
Q

primary prevention drug

A

atorvastatin (20mg) daily

26
Q

primary prevention aim

A

reduce non-HDL-C by >40%

27
Q

secondary prevention drug

A

atorvastatin (80mg) daily, provided after a CV event

28
Q

secondary prevention aim

A

reduce LDL-C to <2mmol/l or non-HDL-C to <2.6 mmol/l

29
Q

atorvastatin contraindications

A

active liver disease, pregnancy, breastfeeding, antiviral drug interactions

30
Q

atorvastatin side effects

A

nausea, indigestion, headaches, nosebleeds, sore throat, cold-like symptoms, constipation, flatulence, diarrhoea

31
Q

ezetimibe

A

inhibits cholesterol absorption at brush border of intestine causing increased LDL receptor expression on hepatocyte cell surface and more cholesterol removal

32
Q

when to offer ezetimibe

A

primary hypercholestreolemia with side effects to statins

33
Q

ezetimibe contraindications (3)

A

increased risk of gallstones, myopathy and rhabdomyolysis, moderate to severe liver impairment

34
Q

ezetimibe side effects

A

hypertension, abdominal pain, diarrhoea, flatulence, increased ALT/AST, headaches, fatigue

35
Q

bempedoic acid

A

inhibits cholesterol synthesis (combined with ezetimibe)

36
Q

when to offer bempedoic acid

A

patients intolerant to statins or contraindicated and LDL-C levels unaffected by ezetimibe

37
Q

bempedoic acid contraindications

A

gout, liver conditions, pregnant or breastfeeding

38
Q

bempedoic acid side effects

A

anaemia, myopathy with statins, deranged LFTs, reduced eGFR, gout, extremity pain

39
Q

when to offer icosapent ethyl

A

triglycerides >1.7 mmol/l and LDL-C 1.04-2.6 mmol/l and established CVD and already on statin

40
Q

icosapent ethyl contraindications

A

allergic to fish, hepatic impairment, atrial fibrillation, bleeding risk

41
Q

icosapent ethyl side effects

A

atrial fibrillation, bleeding, peripheral oedema, gout, musculoskeletal pain, constipation

42
Q

inclisiran

A

increases LDL receptor recycling and expression on hepatocyte cell surface and more cholesterol removal

43
Q

when to offer inclisiran

A

LDL 2.6 mmol/l and established CVD and already on maximal tolerated oral lipid lowering therapy

44
Q

inclisiran warnings

A

high cost drug approval for hospital use and some GPs reluctant to prescribe

45
Q

PCSK9 inhibitors

A

bind PCSK9 to prevent LDL receptor degradation on hepatocyte cell surface and more cholesterol removal

46
Q

PCSK9 inhibitor examples

A

evolocumab, alirocumab

47
Q

PCSK9 inhibitor warnings

A

expensive